1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CCADC0EF0C7BAE2300258CA5002C2D0E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-inside-medtech-compliance-staffing-kpis-digital-innovation-regulatory-quality?opendocument
18
19opendocument
2018.97.9.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Quality, Compliance and Regulatory » Structure,Staffing and Execution

Inside MedTech Compliance: Staffing, KPIs, and Digital Innovation in Regulatory and Quality

ID: 5880


Features:

7 Info Graphics

19 Data Graphics

300+ Metrics

3 Narratives


Pages/Slides: 36


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Inside MedTech Compliance: Staffing, KPIs, and Digital Innovation in Regulatory and Quality”

STUDY OVERVIEW

Next-generation compliance in MedTech is being shaped by three forces: people, performance metrics, and technology. As Regulatory and Quality (RAQA) functions evolve into data-centric, innovation-focused teams, effective workforce planning and digital integration are more essential than ever.

This study investigates the current and emerging landscape of RAQA staffing models, performance measurement, and digital transformation. It examines global staffing levels, outsourcing trends, cost allocation by function, and regional workforce distribution. It also analyzes how AI, robotics, and analytics tools are being adopted to improve efficiency, manage device-generated data, and address rising compliance complexity.

With a focus on modernizing RAQA teams, this research delivers actionable guidance on investing in talent, upgrading KPIs, and implementing the right technologies to drive both compliance and competitive advantage.

KEY TOPICS

  • RAQA global staffing benchmarks
  • Functional split and outsourcing trends
  • KPI effectiveness for regulatory and quality tracking
  • AI, robotics, and digital tool adoption
  • Data ownership and analytics strategies

KEY METRICS

  • Global RAQA staffing headcounts – FTEs including employees and contractors
  • Regional distribution of regulatory and quality teams – breakdown by geography
  • Outsourcing levels – share of contract employees and external consultants
  • RAQA staffing cost benchmarks – percentage of revenue allocated to personnel
  • Spend split by Regulatory Affairs vs. Quality Assurance – functional distribution of expenses
  • RAQA workforce patterns – 5-year history and forward-looking forecasts for the next five years
  • Current regulatory and quality KPI frameworks – adoption and perceived value
  • Top cost pressures – regulatory stressors and compliance cost escalation
  • Strategies to manage RAQA costs – effectiveness ratings
  • Structure and use of analytics – integration of device-generated data
  • Data ownership and intellectual property concerns – perspectives tied to digital and robotic devices
  • Cost-saving opportunities with AI – top applications identified
  • AI and digital tool adoption levels – implementation in RAQA cost control
  • Perceived effectiveness of AI and digital solutions – value assessments from benchmark partners
  • AI maturity stages – current state of deployment within RAQA functions

SAMPLE KEY FINDINGS

  • Total Outsourced Staff: Quality roles are outsourced more frequently (28%) than Regulatory roles (5%), though most RAQA functions continue to rely primarily on in-house employees.

METHODOLOGY

Best Practices, LLC benchmarked RAQA performance across 63 MedTech business units, drawing on data contributed across multiple time periods. The latest update features in-depth insights from 10 top organizations. Participants were segmented by product type—technology-enabled, robotics surgical, and traditional devices—as well as by company size and maturity, including emerging, mid-size, and large organizations.

Industries Profiled:
Medical Device; Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; High Tech; Biotech; Medical; Technology; Consulting; Science


Companies Profiled:
3M - DDSD; Abbott; Abbott Vascular; Accelerate Diagnostics; Acceleron Pharma; Aesculap; Agilent; Alcon; B. Braun; Baxter Healthcare; Beckman Coulter; BIOTRONIK; Boston Scientific; CMR Surgical Ltd; ConMed; Cook Medical; eNeura Therapeutics; Fisher & Paykel Healthcare; FzioMed; Getinge; GRIFOLS; Haemonetics Corporation; Halma; insStem; Johnson & Johnson; Lentigen Corporation; Lifecore Biomedical; Meril Life Sciences; Minnetronix Medical; Molnlycke Health Care; NeedleTech Products; neMedIO; nSpire Health; Onconova Therapeutics; Ortho Clinical Diagnostics; PerkinElmer; Philips; QMS Consulting; Quest Medical; Radius Health; ReShape Lifesciences; ResMed; Sartorius Stedim; Smith & Nephew; Stryker; Teleflex; Thermo Fisher Scientific; Verastem Oncology; Waters Corporation; Wright Medical; Zimmer Biomet; ZimVie

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.